Amlodipine Besylate Tablet
Product Images NDC 50090-5355

4 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 50090-5355). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Amlodipine Besylate (Afcca25d 0e19 4800 A55d 1714067a4400 01)

Amlodipine Besylate (Afcca25d 0e19 4800 A55d 1714067a4400 01)
Chemical structure of Amlodipine Besylate, showing the molecular arrangement of atoms including chlorine, methoxy groups, and a benzene ring sulfonate component.*
FDA Label Image

Figure 1 (Kaplan-Meier Analysis of Composite Clinical Outcomes for Amlodipine versus Placebo)

Figure 1 (Kaplan-Meier Analysis of Composite Clinical Outcomes for Amlodipine versus Placebo)
A Kaplan-Meier curve displaying composite clinical outcomes over 24 months for Amlodipine versus Placebo. The plot shows event rates on the y-axis and time in months on the x-axis. Two lines compare event rates, with Placebo higher than Amlodipine. Numbers at risk are indicated below the x-axis.*
FDA Label Image

Figure 2 (Effects on Primary Endpoint of Amlodipine versus Placebo across Sub-Groups)

Figure 2 (Effects on Primary Endpoint of Amlodipine versus Placebo across Sub-Groups)
A forest plot illustrating hazard ratios with 95% confidence intervals for the effect of Amlodipine versus placebo across patient subgroups. The vertical line at 1.0 separates favoring Amlodipine (left) from placebo (right). Subgroups include overall patients, age groups below and above 65, gender, baseline sitting systolic blood pressure, baseline vessel disease, baseline vessels with stenosis, and PCI-stent strata. Sample sizes per subgroup are indicated.*
FDA Label Image

Label Image (Lbl500905355)

Label Image (Lbl500905355)
The packaging label for Amlodipine Besylate 10 mg oral tablets by A-S Medication Solutions, with NDC 50090-5355-0. The label indicates the product contains 90 tablets per container, and includes dosage information to take 10 mg of amlodipine. Storage instructions specify keeping the tablets at 68 to 77 degrees Fahrenheit, protecting them from light. The label also features a QR code and a package ID.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.